BACKGROUND: The Special Programme for Research and Training in Tropical Diseases recently launched a Mycobacterium tuberculosis strain bank (TDR-TB Strain Bank). OBJECTIVE: To describe the TDR-TB Strain Bank, the characterisation of strains, bank management and the procedure for releasing materials. RESULTS: The TDR-TB Strain Bank consists of 229 clinical M. tuberculosis isolates (single-colony derived cultures) plus five mycobacterial reference strains for purposes of identification. These are available as freeze-dried, viable strains or as heat-inactivated bacterial suspensions, quality controlled for purity, viability and authenticity. Isolates originated from diverse geographical settings and were selected for their resistance profiles against first- and second-line drugs. Low and high levels of resistance were determined by the minimum inhibitory concentrations of isoniazid, rifampicin, ethambutol, streptomycin, ofloxacin, kanamycin, capreomycin, ethionamide and para-aminosalicylic acid. Sequencing for drug resistance mutations was performed on the relevant sections of the rpoB, katG, inhA, embB, rpsL, rrs, gyrA and gyrB genes. Typing using lineage-defining loci of mycobacterial interspersed repetitive unit-variable number tandem repeats indicated that the most important genetic lineages were represented. CONCLUSIONS: The TDR-TB Strain Bank is a high quality bioresource for basic science, supporting the development of new diagnostics and drug-resistant detection tools and providing reference materials for laboratory quality management programmes.
BACKGROUND: The Special Programme for Research and Training in Tropical Diseases recently launched a Mycobacteriumtuberculosis strain bank (TDR-TB Strain Bank). OBJECTIVE: To describe the TDR-TB Strain Bank, the characterisation of strains, bank management and the procedure for releasing materials. RESULTS: The TDR-TB Strain Bank consists of 229 clinical M. tuberculosis isolates (single-colony derived cultures) plus five mycobacterial reference strains for purposes of identification. These are available as freeze-dried, viable strains or as heat-inactivated bacterial suspensions, quality controlled for purity, viability and authenticity. Isolates originated from diverse geographical settings and were selected for their resistance profiles against first- and second-line drugs. Low and high levels of resistance were determined by the minimum inhibitory concentrations of isoniazid, rifampicin, ethambutol, streptomycin, ofloxacin, kanamycin, capreomycin, ethionamide and para-aminosalicylic acid. Sequencing for drug resistance mutations was performed on the relevant sections of the rpoB, katG, inhA, embB, rpsL, rrs, gyrA and gyrB genes. Typing using lineage-defining loci of mycobacterial interspersed repetitive unit-variable number tandem repeats indicated that the most important genetic lineages were represented. CONCLUSIONS: The TDR-TB Strain Bank is a high quality bioresource for basic science, supporting the development of new diagnostics and drug-resistant detection tools and providing reference materials for laboratory quality management programmes.
Authors: Hassan Safi; Subramanya Lingaraju; Anita Amin; Soyeon Kim; Marcus Jones; Michael Holmes; Michael McNeil; Scott N Peterson; Delphi Chatterjee; Robert Fleischmann; David Alland Journal: Nat Genet Date: 2013-09-01 Impact factor: 38.330
Authors: Maha R Farhat; Razvan Sultana; Oleg Iartchouk; Sam Bozeman; James Galagan; Peter Sisk; Christian Stolte; Hanna Nebenzahl-Guimaraes; Karen Jacobson; Alexander Sloutsky; Devinder Kaur; James Posey; Barry N Kreiswirth; Natalia Kurepina; Leen Rigouts; Elizabeth M Streicher; Tommie C Victor; Robin M Warren; Dick van Soolingen; Megan Murray Journal: Am J Respir Crit Care Med Date: 2016-09-01 Impact factor: 21.405
Authors: Manzour Hernando Hazbón; Leen Rigouts; Marco Schito; Matthew Ezewudo; Takuji Kudo; Takashi Itoh; Moriya Ohkuma; Katalin Kiss; Linhuan Wu; Juncai Ma; Moriyuki Hamada; Michael Strong; Max Salfinger; Charles L Daley; Jerry A Nick; Jung-Sook Lee; Nalin Rastogi; David Couvin; Raquel Hurtado-Ortiz; Chantal Bizet; Anita Suresh; Timothy Rodwell; Audrey Albertini; Karen A Lacourciere; Ana Deheer-Graham; Sarah Alexander; Julie E Russell; Rebecca Bradford; Marco A Riojas Journal: Pathog Dis Date: 2018-06-01 Impact factor: 3.166
Authors: Claudio U Köser; Silke Feuerriegel; David K Summers; John A C Archer; Stefan Niemann Journal: Antimicrob Agents Chemother Date: 2012-09-24 Impact factor: 5.191
Authors: Yvonne Linger; Alexander Kukhtin; Julia Golova; Alexander Perov; Peter Qu; Christopher Knickerbocker; Christopher G Cooney; Darrell P Chandler Journal: J Vis Exp Date: 2014-04-25 Impact factor: 1.355
Authors: Yvonne Linger; Alexander Kukhtin; Julia Golova; Alexander Perov; Amine Lambarqui; Lexi Bryant; George B Rudy; Kim Dionne; Stefanie L Fisher; Nicole Parrish; Darrell P Chandler Journal: J Clin Microbiol Date: 2014-04-09 Impact factor: 5.948
Authors: Alexander V Kukhtin; Ryan Norville; Arial Bueno; Peter Qu; Nicole Parrish; Megan Murray; Darrell P Chandler; Rebecca C Holmberg; Christopher G Cooney Journal: Anal Chem Date: 2020-03-24 Impact factor: 6.986